Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001467435-14-000001
Filing Date
2014-06-16
Accepted
2014-06-13 18:13:34
Documents
1
Effectiveness Date
2014-06-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12408
  Complete submission text file 0001467435-14-000001.txt   13487
Mailing Address 1700 OWENS STREET SUITE 585 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 585 SAN FRANCISCO CA 94158 415-655-7560
Presidio Pharmaceuticals, Inc. (Filer) CIK: 0001467435 (see all company filings)

EIN.: 510572796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-195112 | Film No.: 14911171